Loading…

Decline in the estimated glomerular filtration rate (eGFR) following metabolic control and its relationship with baseline eGFR in type 2 diabetes with microalbuminuria or macroalbuminuria

Aims Relationship between baseline eGFR and the rate of decline in eGFR was investigated in diabetic kidney disease. Materials and methods Patients with type 2 diabetes with microalbuminuria (MI) ( n  = 124) or macroalbuminuria (MA) ( n  = 81) received team-based medical care to prevent the developm...

Full description

Saved in:
Bibliographic Details
Published in:Diabetology international 2022-01, Vol.13 (1), p.148-159
Main Authors: Akazawa, Shoichi, Sadashima, Eiji, Sera, Yasunori, Koga, Nobuhiko
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Aims Relationship between baseline eGFR and the rate of decline in eGFR was investigated in diabetic kidney disease. Materials and methods Patients with type 2 diabetes with microalbuminuria (MI) ( n  = 124) or macroalbuminuria (MA) ( n  = 81) received team-based medical care to prevent the development of diabetic kidney disease. The decline in eGFR over 4 years, divided into the first year and subsequent 3 years, was estimated by linear-mixed modeling. Results The eGFR showed a rapid decline during the first year, followed by a slower decline. On multiple regression analysis, the baseline eGFR was positively correlated with HbA1c in MI and negatively correlated with carotid plaque in MI and in MA. Subsequent eGFR decline following 1-year intervention was negatively correlated with the baseline eGFR and HbA1c level at 1 year in MI, whereas it was positively correlated with baseline eGFR and negatively correlated with the amount of proteinuria at 1 year in MA. Even in maintained baseline eGFR(≧ 60 ml/min/1.73 m 2 ) at the first year, when HbA1c ≧ 7.5%, eGFR reduction rate and years to ESKD were much faster and shorter, compared to the group of HbA1c 
ISSN:2190-1678
2190-1686
DOI:10.1007/s13340-021-00517-2